Skip to content

Effect of Block of nerves supplying scalp with drug levobupivacaine and ketamine versus levobupivacaine only on requirement of opioid medicines during and after operation in Patients having brain tumour operations

Effect of Scalp Nerve Block with levobupivacaine and ketamine versus levobupivacaine only on intraoperative opioid requirements and postoperative analgesia in Patients Undergoing supratentorial craniotomy: A Randomized control trial. - nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062724
Enrollment
58
Registered
2024-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Scalp block with ketamine and levobupivacaine: 1mg/kg of Inj Ketamine and 28 mL of 0.5 % levobupivacaine, diluted to a total volume of 30 mL for bilateral scalp block Control Interventi

Sponsors

All India Institute of Medical Sciences, Bathinda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between 18-70 years of age 2. Patients scheduled for elective supratentorial craniotomy, belonging to American Society of Anaesthesiologists (ASA) physical status I, II, or III. 3. Patients undergoing intraoperative pin fixation of the head. 4. Preoperative GCS 15 5. Patients with an anticipated full awakening from general anaesthesia within 2 hours postoperatively.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. History of craniotomy with absent bone flap 2. Frontal craniotomy 3. Known psychiatric disorder 4. Uncontrolled epilepsy 5. Chronic headache. 6. Peri-incisional infection 7. No plan to extubate or expected prolonged mechanical ventilation. 8. Known allergy to NSAIDS, ketamine, or levobupivacaine. 9. Chronic opioid use ( >2 weeks) or history of excessive alcohol or drug abuse 10. Inability to understand the use of NRS. 11. Extremes of body mass index (BMI) ( 35 kg/cm2). 12. Pregnant or breastfeeding. Withdrawal criteria 1. Not awake 2 hours after surgery. 2. Early revision within the first 48 hours. 3. Voluntary withdrawal. 4. Received radiation therapy and chemotherapy postoperatively.

Design outcomes

Primary

MeasureTime frame
The primary outcome of our study will be time of first rescue analgesic administration from the time of test drug administration recorded as the pain-free interval. Timepoint: pain-free interval to be assessed

Secondary

MeasureTime frame
Cumulative dose of intraoperative opioids.Timepoint: duration of anesthesia;Cumulative dose of rescue analgesic requirement in the first 24 hours and 48 hours postoperative period.Timepoint: 24 hours postoperative period 48 hours postoperative period.;Postoperative nausea and vomiting (PONV) assessed at 2, 4, 8, 24, and 48 hours after surgeryTimepoint: 2, 4, 8, 24, and 48 hours after surgery;Postoperative pain scores assessed by NRS. The NRS scores will be recorded at 2, 4, 8, 12, 16, 20, 24, 36, and 48 h after surgery.Timepoint: 2, 4, 8, 12, 16, 20, 24, 36, and 48 h after surgery;Ramsay Sedation ScaleTimepoint: 2,4,8,24 and 48 hours after surgery

Countries

India

Contacts

Public ContactNavneh Samagh

All India Institute of Medical Sciences, Bathinda

navnehsamagh@gmail.com8427264480

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026